These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 11878196

  • 1. The use of chemically modified cyclodextrins in the development of formulations for chemical delivery systems.
    Brewster ME, Loftsson T.
    Pharmazie; 2002 Feb; 57(2):94-101. PubMed ID: 11878196
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Self-assembly of cyclodextrin complexes: aggregation of hydrocortisone/cyclodextrin complexes.
    Messner M, Kurkov SV, Brewster ME, Jansook P, Loftsson T.
    Int J Pharm; 2011 Apr 04; 407(1-2):174-83. PubMed ID: 21237259
    [Abstract] [Full Text] [Related]

  • 4. Cyclodextrins--enabling excipients: their present and future use in pharmaceuticals.
    Thompson DO.
    Crit Rev Ther Drug Carrier Syst; 1997 Apr 04; 14(1):1-104. PubMed ID: 9043816
    [Abstract] [Full Text] [Related]

  • 5. Effect of 2-hydroxypropyl-beta-cyclodextrin on the solubility, stability, and pharmacological activity of the chemical delivery system of TRH analogs.
    Wu WM, Wu J, Bodor N.
    Pharmazie; 2002 Feb 04; 57(2):130-4. PubMed ID: 11878189
    [Abstract] [Full Text] [Related]

  • 6. Cyclodextrins.
    Stella VJ, He Q.
    Toxicol Pathol; 2008 Jan 04; 36(1):30-42. PubMed ID: 18337219
    [Abstract] [Full Text] [Related]

  • 7. Inclusion complexation of diazepam with different cyclodextrins in formulations for parenteral use.
    Holvoet C, Heyden YV, Plaizier-Vercammen J.
    Pharmazie; 2005 Aug 04; 60(8):598-603. PubMed ID: 16124403
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. CDs as solubilizers: effects of excipients and competing drugs.
    Jansook P, Loftsson T.
    Int J Pharm; 2009 Sep 08; 379(1):32-40. PubMed ID: 19524652
    [Abstract] [Full Text] [Related]

  • 11. [Dissolution of nimodipine in an aqueous solution of hydroxyethyl-beta-cyclodextrin and a review of solubility of nimodipine with cyclodextrins].
    Kopecký F, Kopecká B, Kaclík P.
    Ceska Slov Farm; 2003 Jan 08; 52(1):33-8. PubMed ID: 12685332
    [Abstract] [Full Text] [Related]

  • 12. Effect of water-soluble polymers on naproxen complexation with natural and chemically modified beta-cyclodextrins.
    Faucci MT, Mura P.
    Drug Dev Ind Pharm; 2001 Oct 08; 27(9):909-17. PubMed ID: 11763468
    [Abstract] [Full Text] [Related]

  • 13. Self-assembled cyclodextrin aggregates and nanoparticles.
    Messner M, Kurkov SV, Jansook P, Loftsson T.
    Int J Pharm; 2010 Mar 15; 387(1-2):199-208. PubMed ID: 19963052
    [Abstract] [Full Text] [Related]

  • 14. [Amphiphilic cyclodextrins and their applications. Preparation of nanoparticles based on amphiphilic cyclodextrins for biomedical applications].
    Parrot-Lopez H, Perret F, Bertino-Ghera B.
    Ann Pharm Fr; 2010 Jan 15; 68(1):12-26. PubMed ID: 20176159
    [Abstract] [Full Text] [Related]

  • 15. Modulation of release rate and barrier transport of Diclofenac incorporated in hydrophilic matrices: role of cyclodextrins and implications in oral drug delivery.
    Miro A, Rondinone A, Nappi A, Ungaro F, Quaglia F, La Rotonda MI.
    Eur J Pharm Biopharm; 2009 May 15; 72(1):76-82. PubMed ID: 19135532
    [Abstract] [Full Text] [Related]

  • 16. Influence of preparation methodology on solid-state properties of an acidic drug-cyclodextrin system.
    Govindarajan R, Nagarsenker MS.
    J Pharm Pharmacol; 2004 Jun 15; 56(6):725-33. PubMed ID: 15231037
    [Abstract] [Full Text] [Related]

  • 17. Influence of cyclodextrins on the proliferation of HaCaT keratinocytes in vitro.
    Hipler UC, Schönfelder U, Hipler C, Elsner P.
    J Biomed Mater Res A; 2007 Oct 15; 83(1):70-9. PubMed ID: 17380497
    [Abstract] [Full Text] [Related]

  • 18. Comparative interaction of 2-hydroxypropyl-beta-cyclodextrin and sulfobutylether-beta-cyclodextrin with itraconazole: phase-solubility behavior and stabilization of supersaturated drug solutions.
    Brewster ME, Vandecruys R, Peeters J, Neeskens P, Verreck G, Loftsson T.
    Eur J Pharm Sci; 2008 Jul 03; 34(2-3):94-103. PubMed ID: 18420390
    [Abstract] [Full Text] [Related]

  • 19. Study of insolubility problems of dexamethasone and digoxin: cyclodextrin complexation.
    Dilova V, Zlatarova V, Spirova N, Filcheva K, Pavlova A, Grigorova P.
    Boll Chim Farm; 2004 Jul 03; 143(1):20-3. PubMed ID: 15085571
    [Abstract] [Full Text] [Related]

  • 20. Pharmaceutical applications of cyclodextrins: basic science and product development.
    Loftsson T, Brewster ME.
    J Pharm Pharmacol; 2010 Nov 03; 62(11):1607-21. PubMed ID: 21039545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.